Academic Journal
P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Individual Patient Data
العنوان: | P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Individual Patient Data |
---|---|
المؤلفون: | Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten |
المصدر: | HemaSphere, Vol 6, Pp 49-49 (2022) |
بيانات النشر: | Wiley |
سنة النشر: | 2022 |
المجموعة: | Directory of Open Access Journals: DOAJ Articles |
مصطلحات موضوعية: | Diseases of the blood and blood-forming organs, RC633-647.5 |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 2572-9241 |
Relation: | http://journals.lww.com/10.1097/01.HS9.0000890996.84518.13; https://doaj.org/toc/2572-9241; https://doaj.org/article/944d942416844f119d5067af91baa190 |
DOI: | 10.1097/01.HS9.0000890996.84518.13 |
الاتاحة: | https://doi.org/10.1097/01.HS9.0000890996.84518.13 https://doaj.org/article/944d942416844f119d5067af91baa190 |
رقم الانضمام: | edsbas.6A9B1F45 |
قاعدة البيانات: | BASE |
تدمد: | 25729241 |
---|---|
DOI: | 10.1097/01.HS9.0000890996.84518.13 |